GlassScriptPhysician profile
Jeffrey Krause
NPI 1902167497
$4,270.33
in general payments reported to CMS, 2019-2025
13 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.94 · 2022: $99.86 · 2023: $2,527 · 2024: $191 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,388 · Food and Beverage: $1,578 · Travel and Lodging: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,387.60 |
| Food and Beverage | $1,578.39 |
| Travel and Lodging | $126.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,387.60 | 2023 | Senza |
| Abbott Laboratories | $807.32 | 2024-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $337.04 | 2021-2025 | Wavewriter Alpha Prime 16, Avista Mri |
| Globus Medical, INC. | $335.11 | 2025 | Senza |
| Vertos Medical, INC. | $151.16 | 2022-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $71.96 | 2022-2023 | Sprint Pns System |
| Almirall LLC | $35.68 | 2025 | Klisyri |
| Electronic Waveform Lab, INC. | $34.11 | 2025 | |
| Relievant Medsystems, INC. | $30.03 | 2023 | Intracept |
| B. Braun Medical INC. | $28.71 | 2025 | Pencan |
| Fidia Pharma USA INC. | $19.46 | 2025 | Hymovis |
| Vertex Pharmaceuticals Incorporated | $18.23 | 2025 | |
| Currax Pharmaceuticals LLC | $13.92 | 2025 | Contrave, Onzetra Xsail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Krause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.